M C Weinstein
Overview
Explore the profile of M C Weinstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
159
Citations
5926
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Greenes R, Barnett G, Pauker S, Szolovits P, Weinstein M
Yearb Med Inform
. 2016 Sep;
(1):105-110.
PMID: 27668618
The Harvard-MIT-NEMC Research Training Program in Medical Informatics brings together five separate research groups to provide a diversified training experience in Boston with sponsorship by the National Library of Medicine....
2.
de Geus S, Evans D, Bliss L, Eskander M, Smith J, Wolff R, et al.
Eur J Surg Oncol
. 2016 Aug;
42(10):1552-60.
PMID: 27570116
Background: Neoadjuvant therapy is gaining acceptance as a valid treatment option for borderline resectable pancreatic cancer; however, its value for clearly resectable pancreatic cancer remains controversial. The aim of this...
3.
Yazdanpanah Y, Vray M, Meynard J, Losina E, Weinstein M, Morand-Joubert L, et al.
HIV Med
. 2007 Sep;
8(7):439-50.
PMID: 17760736
Objectives: Resistance testing in HIV disease may provide long-term benefits that are not evident from short-term data. Our objectives were to estimate the long-term effectiveness, cost and cost-effectiveness of genotype...
4.
Losina E, Anglaret X, Yazdanpanah Y, Wang B, Toure S, Seage 3rd G, et al.
S Afr Med J
. 2006 Jul;
96(6):526-9.
PMID: 16841136
Objective: To estimate incidence rates of opportunistic diseases (ODs) and mortality for patients with and without a history of OD among HIV-infected patients in Côte d'Ivoire. Methods: Using incidence density...
5.
Marshall D, Kleinman S, Wong J, Aubuchon J, Grima D, Kulin N, et al.
Vox Sang
. 2004 Feb;
86(1):28-40.
PMID: 14984557
Background And Objectives: The aim of this study was to examine the cost-effectiveness of adding nucleic acid testing (NAT) to serological (antibody and antigen) screening protocols for donated blood in...
6.
Yazdanpanah Y, Goldie S, Paltiel A, Losina E, Coudeville L, Weinstein M, et al.
Clin Infect Dis
. 2002 Dec;
36(1):86-96.
PMID: 12491207
A simulation model of human immunodeficiency virus (HIV) disease, which incorporated French data on the progression of HIV disease in the absence of antiretroviral therapy and on cost, was used...
7.
Weinstein M, Toy E, Sandberg E, Neumann P, Evans J, Kuntz K, et al.
Value Health
. 2001 Nov;
4(5):348-61.
PMID: 11705125
The role of models to support recommendations on the cost-effective use of medical technologies and pharmaceuticals is controversial. At the heart of the controversy is the degree to which experimental...
8.
Goldman L, Phillips K, Coxson P, Goldman P, Williams L, Hunink M, et al.
J Am Coll Cardiol
. 2001 Oct;
38(4):1012-7.
PMID: 11583874
Objectives: We sought to estimate the impact and cost-effectiveness of risk factor reductions between 1981 and 1990. Background: Coronary heart disease (CHD) mortality rates have declined dramatically, partly as a...
9.
Cost-effectiveness of earlier initiation of antiretroviral therapy for uninsured HIV-infected adults
Schackman B, Goldie S, Weinstein M, Losina E, Zhang H, Freedberg K
Am J Public Health
. 2001 Aug;
91(9):1456-63.
PMID: 11527782
Objectives: This study was designed to examine the societal cost-effectiveness and the impact on government payers of earlier initiation of antiretroviral therapy for uninsured HIV-infected adults. Methods: A state-transition simulation...
10.
Tice J, Ross E, Coxson P, Rosenberg I, Weinstein M, Hunink M, et al.
JAMA
. 2001 Aug;
286(8):936-43.
PMID: 11509058
Context: A high homocysteine level has been identified as an independent modifiable risk factor for coronary heart disease (CHD) events and death. Since January 1998, the US Food and Drug...